Show simple item record

Schizofrenie: prevence relapsu a opětovné hospitalizace na psychiatrické klinice po léčbě
dc.contributor.advisorBankovská Motlová, Lucie
dc.creatorAarseth, Erling Becker
dc.date.accessioned2018-09-12T11:51:20Z
dc.date.available2018-09-12T11:51:20Z
dc.date.issued2010
dc.identifier.urihttp://hdl.handle.net/20.500.11956/30268
dc.description.abstractIt has in this review article been cited several different studies and sources, all concerning the prevention of relapse of schizophrenia and related psychotic disorders; The different approaches to treatment (programs, type of psychotherapy etc.) have been discussed according to evidence based research and randomized controlled trials. Although some explanations have been given about terms used in the literature, as well as some definitions to enable classifications in future studies, it has been focused only on the preventive measures used in schizophrenia; a detailed description of different subgroups of schizophrenia, as well as detailed descriptions of pharmacology in euroleptics is beyond the scope of this article. The recognition of relapse symptoms was first considered and defined, and the different approaches was then discussed; Outpatient treatment plans and relapse prevention plans, as well as the impact of cognitive behavioral therapy and psychotherapy have been discussed in subsequent chapters. In this section, it was especially focused on the ITAREPS program and its impact on the relapse prevention. The role of medications was then defined and supported with clinical studies and trials.en_US
dc.languageEnglishcs_CZ
dc.language.isoen_US
dc.publisherUniverzita Karlova, 3. lékařská fakultacs_CZ
dc.subjectschizophreniaen_US
dc.subjectrelapse preventionen_US
dc.subjectpsychoeducationen_US
dc.subjectearly warning signen_US
dc.subjectschizofreniecs_CZ
dc.subjectprevence relapsucs_CZ
dc.subjectpsychoedukacecs_CZ
dc.subjectčasné varovánícs_CZ
dc.titleSchizophrenia: Prevention of relapse and re-admission to psychiatric hospital after treatmenten_US
dc.typediplomová prácecs_CZ
dcterms.created2010
dcterms.dateAccepted2010-04-08
dc.description.departmentKlinika psychiatrie a lékařské psychologie - klinika psychiatriecs_CZ
dc.description.departmentDepartment of Psychiatry and Medical Psychology - Department of Psychiatryen_US
dc.description.facultyThird Faculty of Medicineen_US
dc.description.faculty3. lékařská fakultacs_CZ
dc.identifier.repId77800
dc.title.translatedSchizofrenie: prevence relapsu a opětovné hospitalizace na psychiatrické klinice po léčběcs_CZ
dc.identifier.aleph001223577
thesis.degree.nameMUDr.
thesis.degree.levelmagisterskécs_CZ
thesis.degree.discipline-cs_CZ
thesis.degree.discipline-en_US
thesis.degree.programGeneral Medicineen_US
thesis.degree.programVšeobecné lékařstvícs_CZ
uk.thesis.typediplomová prácecs_CZ
uk.taxonomy.organization-cs3. lékařská fakulta::Klinika psychiatrie a lékařské psychologie - klinika psychiatriecs_CZ
uk.taxonomy.organization-enThird Faculty of Medicine::Department of Psychiatry and Medical Psychology - Department of Psychiatryen_US
uk.faculty-name.cs3. lékařská fakultacs_CZ
uk.faculty-name.enThird Faculty of Medicineen_US
uk.faculty-abbr.cs3.LFcs_CZ
uk.degree-discipline.cs-cs_CZ
uk.degree-discipline.en-en_US
uk.degree-program.csVšeobecné lékařstvícs_CZ
uk.degree-program.enGeneral Medicineen_US
thesis.grade.csVýborněcs_CZ
thesis.grade.enExcellenten_US
uk.abstract.enIt has in this review article been cited several different studies and sources, all concerning the prevention of relapse of schizophrenia and related psychotic disorders; The different approaches to treatment (programs, type of psychotherapy etc.) have been discussed according to evidence based research and randomized controlled trials. Although some explanations have been given about terms used in the literature, as well as some definitions to enable classifications in future studies, it has been focused only on the preventive measures used in schizophrenia; a detailed description of different subgroups of schizophrenia, as well as detailed descriptions of pharmacology in euroleptics is beyond the scope of this article. The recognition of relapse symptoms was first considered and defined, and the different approaches was then discussed; Outpatient treatment plans and relapse prevention plans, as well as the impact of cognitive behavioral therapy and psychotherapy have been discussed in subsequent chapters. In this section, it was especially focused on the ITAREPS program and its impact on the relapse prevention. The role of medications was then defined and supported with clinical studies and trials.en_US
uk.file-availabilityV
uk.publication.placePrahacs_CZ
uk.grantorUniverzita Karlova, 3. lékařská fakulta, Klinika psychiatrie a lékařské psychologie - klinika psychiatriecs_CZ
thesis.grade.code1
dc.identifier.lisID990012235770106986


Files in this item

Thumbnail
Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


© 2025 Univerzita Karlova, Ústřední knihovna, Ovocný trh 560/5, 116 36 Praha 1; email: admin-repozitar [at] cuni.cz

Za dodržení všech ustanovení autorského zákona jsou zodpovědné jednotlivé složky Univerzity Karlovy. / Each constituent part of Charles University is responsible for adherence to all provisions of the copyright law.

Upozornění / Notice: Získané informace nemohou být použity k výdělečným účelům nebo vydávány za studijní, vědeckou nebo jinou tvůrčí činnost jiné osoby než autora. / Any retrieved information shall not be used for any commercial purposes or claimed as results of studying, scientific or any other creative activities of any person other than the author.

DSpace software copyright © 2002-2015  DuraSpace
Theme by 
@mire NV